| scholarly article | Q13442814 |
| P50 | author | Julian Parkhill | Q16773696 |
| Marc A. Martí‐Renom | Q37840429 | ||
| Claudio U Köser | Q42421440 | ||
| Sharon Peacock | Q44172566 | ||
| Estee Torok | Q56550582 | ||
| Josephine M Bryant | Q56815996 | ||
| Matthew J Ellington | Q93060687 | ||
| Jennifer Becq | Q114726638 | ||
| P2093 | author name string | Andrew J Carmichael | |
| Geoffrey P Smith | |||
| P2860 | cites work | Routine use of microbial whole genome sequencing in diagnostic and public health microbiology | Q28728617 |
| The future of molecular diagnostics for drug-resistant tuberculosis | Q30455525 | ||
| Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study | Q31107101 | ||
| Microevolution of extensively drug-resistant tuberculosis in Russia | Q35864738 | ||
| Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis | Q40066961 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| Mycobacterium tuberculosis | Q130971 | ||
| whole genome sequencing | Q2068526 | ||
| P304 | page(s) | 290-292 | |
| P577 | publication date | 2013-07-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis | |
| P478 | volume | 369 |
| Q26999868 | A microbiological revolution meets an ancient disease: improving the management of tuberculosis with genomics |
| Q28068503 | Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship |
| Q37833917 | Bacterial genome sequencing in clinical microbiology: a pathogen-oriented review |
| Q86852508 | Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions |
| Q42656497 | Bacterial whole-genome sequencing revisited: portable, scalable, and standardized analysis for typing and detection of virulence and antibiotic resistance genes |
| Q91706429 | Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction |
| Q35311983 | Capturing the cloud of diversity reveals complexity and heterogeneity of MRSA carriage, infection and transmission |
| Q34968760 | Characterizing the genetic basis of bacterial phenotypes using genome-wide association studies: a new direction for bacteriology |
| Q38268747 | Classical and new assays for detecting drug resistance in tuberculosis |
| Q35455573 | Clinical application of whole-genome sequencing to inform treatment for multidrug-resistant tuberculosis cases |
| Q92434251 | Clinical challenges in the era of multiple and extensively drug-resistant tuberculosis |
| Q30207754 | Clinical laboratory response to a mock outbreak of invasive bacterial infections: a preparedness study. |
| Q38901011 | Clinical metagenomics for the management of hospital- and healthcare-acquired pneumonia. |
| Q40097858 | Clinical metagenomics of bone and joint infections: a proof of concept study. |
| Q26752636 | Clinical use of whole genome sequencing for Mycobacterium tuberculosis |
| Q28607255 | Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform |
| Q42737698 | Comment on: characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array |
| Q28546999 | Comparative Evaluation of Sloppy Molecular Beacon and Dual-Labeled Probe Melting Temperature Assays to Identify Mutations in Mycobacterium tuberculosis Resulting in Rifampin, Fluoroquinolone and Aminoglycoside Resistance |
| Q90100518 | Comparative fitness analysis of D-cycloserine resistant mutants reveals both fitness-neutral and high-fitness cost genotypes |
| Q35915975 | Comparison of Sample Preparation Methods Used for the Next-Generation Sequencing of Mycobacterium tuberculosis |
| Q45926221 | Complex genetics of drug resistance in Mycobacterium tuberculosis. |
| Q46589487 | Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance |
| Q21128711 | Culture-independent detection and characterisation of Mycobacterium tuberculosis and M. africanum in sputum samples using shotgun metagenomics on a benchtop sequencer |
| Q92180644 | Deciphering drug resistance in Mycobacterium tuberculosis using whole-genome sequencing: progress, promise, and challenges |
| Q36071093 | Deep Whole-Genome Sequencing to Detect Mixed Infection of Mycobacterium tuberculosis |
| Q28547220 | Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing |
| Q38682808 | Diagnosis of Tuberculosis in HIV Co-infected Individuals: Current Status, Challenges and Opportunities for the Future |
| Q26752536 | Diagnostic 'omics' for active tuberculosis |
| Q39524649 | Differences in T-cell responses between Mycobacterium tuberculosis and Mycobacterium africanum-infected patients |
| Q92667180 | Direct transmission of within-host Mycobacterium tuberculosis diversity to secondary cases can lead to variable between-host heterogeneity without de novo mutation: A genomic investigation |
| Q28551469 | Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country |
| Q54205199 | Dissecting whole-genome sequencing-based online tools for predicting resistance in Mycobacterium tuberculosis: can we use them for clinical decision guidance? |
| Q34930530 | Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches |
| Q40957415 | Draft Genome Sequence of a Drug-Susceptible New Zealand Isolate of Mycobacterium tuberculosis Lineage 3. |
| Q41895871 | Draft Genome Sequence of a Multidrug-Resistant New Zealand Isolate of Mycobacterium tuberculosis Lineage 3. |
| Q41765905 | Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in Ireland |
| Q33584660 | Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand |
| Q38179033 | Drug resistance to Mycobacterium tuberculosis: from the traditional Chinese view to modern systems biology |
| Q64234748 | Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study |
| Q92890791 | Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing |
| Q31148646 | Evaluation of Machine Learning and Rules-Based Approaches for Predicting Antimicrobial Resistance Profiles in Gram-negative Bacilli from Whole Genome Sequence Data |
| Q92668753 | Evolution of Mycobacterium tuberculosis complex lineages and their role in an emerging threat of multidrug resistant tuberculosis in Bamako, Mali |
| Q47632774 | Evolution of Phenotypic and Molecular Drug Susceptibility Testing |
| Q27016579 | Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy |
| Q60925773 | First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon |
| Q38999525 | Genetic Determinants of Drug Resistance in Mycobacterium tuberculosis and Their Diagnostic Value |
| Q42714470 | Genetic diversity within Mycobacterium tuberculosis complex impacts on the accuracy of genotypic pyrazinamide drug-susceptibility assay |
| Q36826330 | Genetic signatures of Mycobacterium tuberculosis Nonthaburi genotype revealed by whole genome analysis of isolates from tuberculous meningitis patients in Thailand. |
| Q40936781 | Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDR Mycobacterium tuberculosis |
| Q48190673 | Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis |
| Q58493506 | Genomic Analysis of Bacterial Outbreaks |
| Q35676292 | Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing |
| Q36844683 | Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance. |
| Q38987535 | Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes |
| Q38808071 | Genomics and the evolution of antibiotic resistance |
| Q42213160 | Health care: Bring microbial sequencing to hospitals |
| Q37733149 | High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova |
| Q59806888 | Highlights on the Application of Genomics and Bioinformatics in the Fight Against Infectious Diseases: Challenges and Opportunities in Africa |
| Q41927847 | Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis |
| Q35193200 | Integration of whole-genome sequencing into infection control practices: the potential and the hurdles |
| Q38225730 | Isoniazid-resistant tuberculosis in Birmingham, United Kingdom, 1999-2010. |
| Q34340287 | KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes. |
| Q35157830 | Long term effect of gut microbiota transfer on diabetes development |
| Q41566433 | Magnitude and sources of bias in the detection of mixed strain M. tuberculosis infection |
| Q28389409 | Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria |
| Q41599957 | Microbial sequencing to improve individual and population health |
| Q49332451 | Molecular Diagnosis of Tuberculosis. |
| Q91737856 | More than merely drug resistance |
| Q38829192 | Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools |
| Q35293726 | New methods for identifying infectious diseases. |
| Q60907631 | Next-Generation Whole Genome Sequencing: Opportunities and Challenges |
| Q38210363 | Novel diagnostics and therapeutics for drug-resistant tuberculosis |
| Q41452335 | Novel laboratory diagnostic tests for tuberculosis and their potential role in an integrated and tiered laboratory network |
| Q51574982 | Personalizing therapy for multidrug resistant TB: the potential of Rapid Whole Genome Sequencing. |
| Q30927278 | PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data |
| Q38863350 | Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex |
| Q55260133 | Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda. |
| Q37546274 | Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens |
| Q35933217 | Pyrosequencing on a glass surface |
| Q37132034 | Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study |
| Q35757756 | Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples |
| Q27342229 | Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis |
| Q35644365 | Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences |
| Q36875446 | Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China |
| Q35076491 | Rapid single-colony whole-genome sequencing of bacterial pathogens |
| Q28603336 | Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study |
| Q37434270 | Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting. |
| Q39014173 | Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis |
| Q41991754 | Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance |
| Q27004697 | Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates |
| Q74434471 | TB resistance revealed |
| Q30585056 | The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine |
| Q30235074 | The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis |
| Q40483822 | The essential mycobacterial amidotransferase GatCAB is a modulator of specific translational fidelity. |
| Q39402027 | The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know? |
| Q38210265 | Totally drug-resistant tuberculosis and adjunct therapies. |
| Q35661922 | Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing |
| Q35868609 | Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results |
| Q57235679 | Tuberculosis |
| Q36325978 | Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial |
| Q41431442 | Validation of β-lactam minimum inhibitory concentration predictions for pneumococcal isolates with newly encountered penicillin binding protein (PBP) sequences |
| Q46319545 | What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis. |
| Q28547769 | Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation |
| Q91837162 | Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing |
| Q64117158 | Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis |
| Q50098804 | Whole genome sequencing for the management of drug-resistant TB in low income high TB burden settings: Challenges and implications |
| Q34465192 | Whole genome sequencing in clinical and public health microbiology |
| Q38828639 | Whole genome sequencing of Mycobacterium tuberculosis for detection of recent transmission and tracing outbreaks: A systematic review. |
| Q38317473 | Whole genome sequencing: a new paradigm in the surveillance and control of human tuberculosis |
| Q37833994 | Whole-Genome Enrichment Using RNA Probes and Sequencing of Chlamydia trachomatis Directly from Clinical Samples |
| Q28553483 | Whole-Genome Sequencing Analysis of Serially Isolated Multi-Drug and Extensively Drug Resistant Mycobacterium tuberculosis from Thai Patients |
| Q37611856 | Whole-Genome Sequencing of Mycobacterium tuberculosis Provides Insight into the Evolution and Genetic Composition of Drug-Resistant Tuberculosis in Belarus. |
| Q36084640 | Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study |
| Q41677504 | Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria. |
| Q37229528 | Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar |
| Q34142073 | Whole-genome sequencing to control antimicrobial resistance |
| Q36333485 | Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment |
Search more.